![](/img/cover-not-exists.png)
6612 POSTER Disease stabilization (SD) as a surrogate end-point in advanced non-small-cell lung cancer (NSCLC) patients treated with erlotinib (E) or gefitinib (G)
Grossi, F., Defferrari, C., Brianti, A., Dal Bello, M.G., Loprevite, M., Catania, G., Pronzato, P.Volume:
5
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(07)71440-4
Date:
September, 2007
File:
PDF, 58 KB
english, 2007